Literature DB >> 6314570

Cell-mediated immunity against Epstein-Barr virus infected B lymphocytes.

E Klein, M G Masucci.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6314570     DOI: 10.1007/bf00201957

Source DB:  PubMed          Journal:  Springer Semin Immunopathol        ISSN: 0344-4325


× No keyword cloud information.
  57 in total

1.  Cells containing Epstein--Barr nuclear antigen (EBNA) in peripheral blood.

Authors:  L Gergely; J Czeglédy; L Váczi; A Szalka; E Berényi
Journal:  Acta Microbiol Acad Sci Hung       Date:  1979

2.  Enhanced destruction of lymphoid cell lines by peripheral blood leukocytes taken from patients with acute infectious mononucleosis.

Authors:  L M Hutt; Y T Huang; H E Dascomb; J S Pagano
Journal:  J Immunol       Date:  1975-07       Impact factor: 5.422

3.  Human spontaneous killer cells selective for tumour-derived target cells.

Authors:  M Jondal; C Spine; S Targan
Journal:  Nature       Date:  1978-03-02       Impact factor: 49.962

4.  Characterization of thymus-derived lymphocyte subsets in acute Epstein-Barr virus-induced infectious mononucleosis.

Authors:  B F Haynes; R T Schooley; J E Grouse; C R Payling-Wright; R Dolin; A S Fauci
Journal:  J Immunol       Date:  1979-02       Impact factor: 5.422

5.  The role of gene dosage and genetic transpositions in carcinogenesis.

Authors:  G Klein
Journal:  Nature       Date:  1981-11-26       Impact factor: 49.962

6.  Long-term T-cell-mediated immunity to Epstein-Barr virus in man. III. Activation of cytotoxic T cells in virus-infected leukocyte cultures.

Authors:  D J Moss; A B Rickinson; J H Pope
Journal:  Int J Cancer       Date:  1979-05-15       Impact factor: 7.396

7.  Lymphocyte transformation induced by autologous cells. III. Lymphoblast-induced lymphocyte to stimulation does not correlate with EB viral antigen expression or immunity.

Authors:  M E Weksler
Journal:  J Immunol       Date:  1976-02       Impact factor: 5.422

8.  Cell-mediated immune reactions in three patients with malignant lymphoproliferative diseases in remission and abnormally high Epstein-Barr virus antibody titers.

Authors:  M G Masucci; R Szigeti; I Ernberg; M Björkholm; H Mellstedt; G Henle; W Henle; G Pearson; G Masucci; E Svedmyr; B Johansson; G Klein
Journal:  Cancer Res       Date:  1981-11       Impact factor: 12.701

9.  Cytotoxic T cell recognition of Epstein-Barr virus-infected B cells. II. Blocking studies with monoclonal antibodies to HLA determinants.

Authors:  L E Wallace; D J Moss; A B Rickinson; A J McMichael; M A Epstein
Journal:  Eur J Immunol       Date:  1981-09       Impact factor: 5.532

10.  Suppression of in vitro Epstein-Barr virus infection. A new role for adult human T lymphocytes.

Authors:  D A Thorley-Lawson; L Chess; J L Strominger
Journal:  J Exp Med       Date:  1977-08-01       Impact factor: 14.307

View more
  2 in total

1.  Human B lymphocytes immortalization by Epstein-Barr virus in the presence of cyclosporin A.

Authors:  F Pelloquin; J P Lamelin; G M Lenoir
Journal:  In Vitro Cell Dev Biol       Date:  1986-12

2.  Impaired autologous mixed lymphocyte reaction (AMLR) in patients with ataxia-telangiectasia and their family members.

Authors:  N Lahat; N Zelnik; P Froom; A Kinarty; A Etzioni
Journal:  Clin Exp Immunol       Date:  1988-10       Impact factor: 4.330

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.